Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Modified Rankin Scale (mRS) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Modified Rankin Scale (mRS)?
The Modified Rankin Scale (mRS) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in neurology practice. The Modified Rankin Scale (mRS) is the most widely used clinical outcome measure for stroke clinical trials. It runs from 0-6, measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke. Clinical scoring tools like Modified Rankin Scale (mRS) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
An mRS of 0-2 is often used as the primary endpoint for a "good clinical outcome" in acute stroke trials (e.g., assessing the benefit of tPA or mechanical thrombectomy).
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Modified Rankin Scale (mRS):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 2 | Favorable Outcome | green |
| 3 – 5 | Poor Outcome (Disability) | orange |
| ≥ 6 | Dead | red |
When to Exercise Caution
It is highly subjective with significant inter-rater variability, though structured interviews have been developed to improve reliability.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
Related Neurology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Neurology:
Glasgow Coma Scale (GCS)
Assesses the level of consciousness after neurological injury.
ABCD² Score for TIA
Estimates stroke risk after a transient ischemic attack (TIA).
Pediatric Glasgow Coma Scale (pGCS)
Assesses level of consciousness in pre-verbal children and infants.
Hunt and Hess Scale
Predicts mortality in subarachnoid hemorrhage (SAH).
Fisher Grade
Predicts the risk of cerebral vasospasm after subarachnoid hemorrhage.
Intracerebral Hemorrhage (ICH) Score
Estimates 30-day mortality for spontaneous intracerebral hemorrhage.